Abstract
BACKGROUNDS AND AIMS: Insulin resistance related to obesity and diabetes is characterized by an increase in plasma TG-rich lipoprotein concentrations. Apolipoprotein (apo) E plays a crucial role in the metabolism of these lipoproteins and particularly in the hepatic clearance of their remnants. The aim of this study was to explore apoE kinetics of obese subjects and to determine what parameters could influence its metabolism.
METHODS: Using stable-isotope labelling technique ([2H3]-leucine-primed constant infusion) and monocompartmental model (SAAM II computer software), we have studied the plasma kinetics of very-low-density lipoprotein (VLDL) and high-density lipoprotein (HDL) apoE in 12 obese subjects (body mass index (BMI) 27.4–36.6 kg/m2): Seven were type 2 diabetics (age 47–65 y; HbA1c 7.1–10.2%) and five were non-diabetics (age 40–51 y, HbA1c: 4.9–5.3%). Six of the diabetic subjects were insulin resistant as assessed by insulin sensitivity index (HOMA 2.6–10.0), while non-diabetic subjects were all insulin sensitive (HOMA 1.2–2.1).
RESULTS: Plasma VLDL and HDL apoE concentrations were significantly higher in diabetic than in non-diabetic subjects (5.74±1.60 vs 1.46±1.74 mg/l, P<0.01 and 17.81±6.67 vs 9.97±3.32 mg/l, P<0.05). These increased levels were associated with significantly higher absolute production rate (APR) of VLDL and HDL apoE (0.714±0.343 vs 0.130±0.200 mg/kg/day, P<0.01, and 0.197±0.087 vs 0.080±0.060 mg/kg/day, P<0.05, respectively) while no significant difference was found for fractional catabolic rate (FCR) of VLDL and HDL apoE (3.44±1.64 vs 1.97±0.84/day and 0.30±0.12 vs 0.19±0.09/day, respectively). In the whole population, BMI was not correlated with any of apoE kinetic data. HOMA was positively correlated with FCR of VLDL apoE (r=0.64, P<0.05) and tended to be correlated with APR of VLDL apoE (r=0.58, P=0.06). HbA1c was positively correlated with APR and FCR of both VLDL apoE (r=0.91 and 0.78, P<0.01, respectively) and HDL apoE (r=0.66 and 0.69, P<0.05, respectively).
CONCLUSION: Obese diabetics are characterized by elevated VLDL and HDL apoE levels associated with enhancement of VLDL and HDL apoE production rates. Whereas obesity did not influence apoE kinetic parameters in itself, insulin resistance may lead to an increase in VLDL apoE production and fractional catabolic rates. Diabetes and the glycemic control may also specifically influence the kinetics of both VLDL and HDL apoE. All together, these disorders should explain at least part of the increase in VLDL and HDL apoE observed in diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Semenkovich CF, Heinecke JW . The mystery of diabetes and atherosclerosis. Time for a new plot Diabetes 1997 46: 327–334.
Van Gal LF, Zhang A, Steijaert MM, Leeuw IH . Human obesity: from lipid abnormalities to lipid oxidation Int J Obes Relat Metab Disord 1995 19: 521–526.
Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE . Weight as a risk factor for clinical diabetes in women Am J Epidemiol 1990 132: 501–513.
Colditz GA, Willet WC, Rotnitzky A, Manson JE . Weight gain as a risk factor for clinical diabetes mellitus in woman Ann Intern Med 1995 122: 481–486.
Kahn BB, Flier JS . Obesity and insulin resistance J Clin Invest 2000 106: 473–481.
Reaven GM . Role of insulin resistance in human disease Diabetes 1988 37: 1595–1607.
Ginsberg HN . Insulin resistance and cardiovascular disease J Clin Invest 2000 106: 453–458.
Gregg RE, Brewer HB Jr . The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in human Clin Chem 1988 34: B28–B32.
Mahley RW, Ji Z-S . Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J Lipid Res 1999 40: 1–16.
Zhang SH, Reddick RL, Piedrarita JA, Maeda N . Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 1992 258: 468–472.
Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL . Severe hypercholesterolemia and atherosclerosis in apoE deficient mice created by homologous recombination in ES cell Cell 1992 71: 343–353.
Blum CB . Dynamics of apoE metabolism in humans J Lipid Res 1982 23: 1308–1316.
Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer HB . Familial apolipoprotein E deficiency J Clin Invest 1986 78: 1206–1219.
Gregg RE, Zech LA, Schaefer EJ, Brewer HB Jr . Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E Science 1981 211: 584–585.
Maugeais C, Tietge UJF, Tsukamoto K, Glick JM, Rader DJ . Hepatic apolipoprotein E expression promotes very low density lipoprotein–apolipoprotein B production in vivo in mice J Lipid Res 2000 41: 1673–1679.
Mensenkamp AR, Jong MC, Van Goor H, Van Luyn MJA, Bloks V, Havinga R, Voshol PJ, Hofker MH, Van Dijk KW, Havekes LM, Kuipers F . Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver J Biol Chem 1999 274: 35711–35718.
Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 240: 622–630.
Miyata M, Smith JD . Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloïd peptides Nat Genet 1996 14: 55–61.
Havel RJ, Kane JP, Kashyap ML . Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man J Clin Invest 1973 52: 32–38.
Gibson JC, Brown WV . Effect of lipoprotein lipase and hepatic triglycerides lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins Atherosclerosis 1988 75: 45–55.
Jeppensen J, Hollenbeck CB, Zhou MY, Coulston AM, Jones C, Chen YD, Reaven GM . Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity and postprandial lipemia Arterioscler Thromb Vasc Biol 1995 15: 320–324.
Bard JM, Charles MA, Juhan-Vague I, Vague P, André P, Safar M, Fruchart JC, Eschwège E . on behalf of the BIGPRO study group Accumulation of triglycerides-rich lipoproteins in subjects with abdominal obesity. The biguanides and the prevention of the risk of obesity (BIGPRO)1-study Arterioscler Thromb Vasc Biol 2001 21: 407–414.
Howard BV . Lipoprotein in diabetes mellitus J Lipid Res 1987 28: 613–628.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostatic model assessment: insulin resistance and cell function from fasting glucose and insulin concentrations in man Diabetologia 1985 28: 412–419.
Chapman MJ, Goldstein S, Lagrange D, Laplaud PM . A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum J Lipid Res 1981 22: 339–358.
Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 1972 18: 499–502.
Menzel H-J, Utermann G . Apolipoprotein E phenotyping from serum by Western Blotting Electrophoresis 1986 7: 492–495.
Laemmli UK . Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature 1970 227: 680–685.
Foster DM, Barrett PHR, Toffolo G, Beltz WF, Cobelli C . Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data J Lipid Res 1993 34: 2193–2205.
Frénais R, Nazih H, Ouguerram K, Maugeais C, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M . In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism in patients with type II diabetes mellitus J Clin Endocrinol Metab 2001 86: 1962–1967.
Iverius PH, Brunzell JD . Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme Am J Physiol 1985 249: E107–E114.
Henderson A, Richmond W, Elkeles RS . Hepatic and lipoprotein lipases selectively assayed in postheparin plasma Clin Chem 1993 39: 218–223.
Pont F, Duvillard L, Verges B, Gambert P . Development of compartmental models in stable-isotope experiments: application to lipid metabolism Arterioscler Thromb Vasc Biol 1998 6: 853–860.
Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG . Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation J Clin Invest 1991 88: 270–281.
Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley RW, Assman G, Eckardstein AV . Low dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma Proc Natl Acad Sci USA 1998 95: 7585–7590.
Van't Hooft F, Havel RJ . Metabolism of chromatographically separated rat serum lipoproteins specifically labeled with 125I-apolipoprotein E J Biol Chem 1981 256: 3963–3968.
Blanchette-Mackie EJ, Scow RO . Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons: electron microscope cytochemical study J Biol Chem 1971 51: 1–25.
Batal R, Tremblay M, Barrett PHR, Jacques H, Fredenrich A, Mamer O, Davignon J, Cohn JS . Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects J Lipid Res 2000 41: 706–718.
Millar JS, Lichtenstein AH, Dolnikowski GG, Ordovas JM, Schaefer EJ . Proposal of a multicomparmental model for use in the study of apolipoprotein E metabolism Metabolism 1998 47: 922–928.
Taskinen M-R, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV . The effects of non-insulin-dependent diabetes mellitus on VLDL triglyceride and VLDL apoB metabolism: studies before and after sulfonyl urea therapy Diabetes 1986 35: 1268–1277.
Weisweiler P, Drosner M, Schwandt P . Dietary effects on very low density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 1982 23: 101–103.
Rensen PCN, Van Berkel TJC . Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich emulsions in vitro and in vivo J Biol Chem 1996 271: 14791–14799.
Huang Y, Liu XQ, Rall SCJ, Mahley RW . Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipase-mediated lipolysis of triglyceride-rich lipoprotein J Biol Chem 1998 273: 17483–17490.
Lin CY, Duan HW, Mazzone T . Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous vs exogenous apolipoprotein E J Lipid Res 1999 40: 1618–1626.
Paka L, Kako Y, Obunike JC, Pillarisetti S . Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein E J Biol Chem 1999 274: 4816–4823.
Riddell DR, Graham A, Owen JS . Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxyde pathway. Implications for vascular disease J Biol Chem 1997 272: 89–95.
Bach-Ngohou K, Nazih H, Nazih-Sanderson F, Zaïr Y, LeCarrer D, Krempf M, Bard JM . Negative and independent influence of apolipoprotein E on C-Reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo Int J Obes Relat Metab Disord 2001 25: 1752–1758.
Acknowledgements
The authors are very grateful to Mrs C Levalegant and Mr J Friburg for their excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bach-Ngohou, K., Ouguerram, K., Nazih, H. et al. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Int J Obes 26, 1451–1458 (2002). https://doi.org/10.1038/sj.ijo.0802149
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802149
Keywords
This article is cited by
-
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
Cardiovascular Diabetology (2022)
-
APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
Scientific Reports (2017)